Illinois Compiled Statutes 225 ILCS 85/9.6 – Administration of vaccines and therapeutics by registered pharmacy …
Current as of: 2024 | Check for updates
|
Other versions
Administration of vaccines and therapeutics by registered pharmacy technicians and student pharmacists.
(a) Under the supervision of an appropriately trained pharmacist, a registered pharmacy technician or student pharmacist may administer COVID-19 and influenza vaccines subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the United States Food and Drug Administration, subject to the following conditions:
(1) the vaccination must be ordered by the
(a) Under the supervision of an appropriately trained pharmacist, a registered pharmacy technician or student pharmacist may administer COVID-19 and influenza vaccines subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the United States Food and Drug Administration, subject to the following conditions:
Terms Used In Illinois Compiled Statutes 225 ILCS 85/9.6
- United States: may be construed to include the said district and territories. See Illinois Compiled Statutes 5 ILCS 70/1.14
(1) the vaccination must be ordered by the
supervising pharmacist;
|
(2) the supervising pharmacist must be readily and
immediately available to the immunizing pharmacy technician or student pharmacist;
|
(3) the pharmacy technician or student pharmacist
must complete a practical training program that is approved by the Accreditation Council for Pharmacy Education and that includes hands-on injection technique training and training in the recognition and treatment of emergency reactions to vaccines;
|
(4) the pharmacy technician or student pharmacist
must have a current certificate in basic cardiopulmonary resuscitation;
|
(5) the pharmacy technician or student pharmacist
must complete, during the relevant licensing period, a minimum of 2 hours of immunization-related continuing pharmacy education that is approved by the Accreditation Council for Pharmacy Education;
|
(6) the supervising pharmacist must comply with all
relevant recordkeeping and reporting requirements;
|
(7) the supervising pharmacist must be responsible
for complying with requirements related to reporting adverse events;
|
(8) the supervising pharmacist must review the
vaccine registry or other vaccination records prior to ordering the vaccination to be administered by the pharmacy technician or student pharmacist;
|
(9) the pharmacy technician or student pharmacist
must, if the patient is 18 years of age or younger, inform the patient and the adult caregiver accompanying the patient of the importance of a well-child visit with a pediatrician or other licensed primary-care provider and must refer patients as appropriate;
|
(10) in the case of a COVID-19 vaccine, the
vaccination must be ordered and administered according to the Advisory Committee on Immunization Practices’ COVID-19 vaccine recommendations;
|
(11) in the case of a COVID-19 vaccine, the
supervising pharmacist must comply with any applicable requirements or conditions of use as set forth in the Centers for Disease Control and Prevention COVID-19 vaccination provider agreement and any other federal requirements that apply to the administration of COVID-19 vaccines being administered; and
|
(12) the registered pharmacy technician or student
pharmacist and the supervising pharmacist must comply with all other requirements of this Act and the rules adopted thereunder pertaining to the administration of drugs.
|
(b) Under the supervision of an appropriately trained pharmacist, a registered pharmacy technician or student pharmacist may administer COVID-19 therapeutics subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the United States Food and Drug Administration, subject to the following conditions:
(1) the COVID-19 therapeutic must be authorized,
(1) the COVID-19 therapeutic must be authorized,
approved or licensed by the United States Food and Drug Administration;
|
(2) the COVID-19 therapeutic must be administered
subcutaneously, intramuscularly, or orally in accordance with the United States Food and Drug Administration approval, authorization, or licensing;
|
(3) a pharmacy technician or student pharmacist
practicing pursuant to this Section must complete a practical training program that is approved by the Accreditation Council for Pharmacy Education and that includes hands-on injection technique training, clinical evaluation of indications and contraindications of COVID-19 therapeutics training, training in the recognition and treatment of emergency reactions to COVID-19 therapeutics, and any additional training required in the United States Food and Drug Administration approval, authorization, or licensing;
|
(4) the pharmacy technician or student pharmacist
must have a current certificate in basic cardiopulmonary resuscitation;
|
(5) the pharmacy technician or student pharmacist
must comply with any applicable requirements or conditions of use that apply to the administration of COVID-19 therapeutics;
|
(6) the supervising pharmacist must comply with all
relevant recordkeeping and reporting requirements;
|
(7) the supervising pharmacist must be readily and
immediately available to the pharmacy technician or student pharmacist; and
|
(8) the registered pharmacy technician or student
pharmacist and the supervising pharmacist must comply with all other requirements of this Act and the rules adopted thereunder pertaining to the administration of drugs.
|